Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057404 · ClinicalTrials.gov registry record
Smartphone Twelve Lead Electrocardiogram Utility In ST Elevation Myocardial Infarction
A clinical trial of ST Elevated Myocardial Infarction, sponsored by INTEGRIS Baptist Medical Center.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04057404 is a study of ST Elevated Myocardial Infarction that has completed, run by INTEGRIS Baptist Medical Center. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04057404, a study of ST Elevated Myocardial Infarction, has completed, sponsored by INTEGRIS Baptist Medical Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to determine if the Smartphone electrocardiogram (ECG) is an acceptable replacement for a standard ECG in the identification of ST elevation myocardial infarction (STEMI).
Conditions Studied
Interventions
- DEVICE Alivecor Heart Monitor
Study Locations (1)
Oklahoma
- INTEGRIS Baptist Medical Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04057404
The ClinicalTrials.gov registry entry for NCT04057404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INTEGRIS Baptist Medical Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ST Elevated Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which Alivecor Heart Monitor is the first listed.
NCT04057404 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04057404 about?
NCT04057404 is a clinical study titled "Smartphone Twelve Lead Electrocardiogram Utility In ST Elevation Myocardial Infarction". The primary objective is to determine if the Smartphone electrocardiogram (ECG) is an acceptable replacement for a standard ECG in the identification of ST elevation myocardial infarction (STEMI).
What is the current status of trial NCT04057404?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2015-09. Estimated completion is 2018-07-30.
What conditions does trial NCT04057404 study?
This clinical trial studies the following conditions: ST Elevated Myocardial Infarction.
What interventions are being tested in trial NCT04057404?
The interventions under investigation include: Alivecor Heart Monitor (DEVICE).
Who is sponsoring clinical trial NCT04057404?
This trial is sponsored by INTEGRIS Baptist Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04057404 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.